Teprotumumab for Thyroid Eye Disease-related Strabismus.

Liane O DallalzadehGeorge A VillatoroLillian ChenMyung S SimMansoor MovagharShira L RobbinsJustin N KarlinMonica R KhitriFederico G VelezBobby S KornJoseph L DemerDaniel B RootmanDavid B GranetDon O Kikkawa

Published in: Ophthalmic plastic and reconstructive surgery (2024)

Teprotumumab produced a statistically significant reduction in vertical but not horizontal strabismus angles in primary position at distance. Extraocular motility in all 4 ductions also improved. A substantial minority of patients still required strabismus surgery following teprotumumab.

Keyphrases

end stage renal disease
chronic kidney disease
minimally invasive
newly diagnosed
patient reported outcomes
atrial fibrillation
biofilm formation
percutaneous coronary intervention
patient reported